Globus Medical Reports Fourth Quarter and Full Year 2025 Results

About this update from Globus Medical, Inc.

[{"type":"image","alt":"Globus Medical","displaySize":"","headline":null,"caption":"Globus Medical","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":236,"url":"https://media.zenfs.com/en/globenewswire.com/00da90d72bee150b4be4104613ae2ce4"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/HbC9jzNGkCK8ASuuAaxfXw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTMzMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/00da90d72bee150b4be4104613ae2ce4","width":300,"height":236}},"lazy":false},{"type":"text","content":"AUDUBON, Pa., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology solutions company, today announced its financial results for the fourth quarter and year ended December 31, 2025.","length":233,"tagName":"p"},{"type":"text","content":"Fourth Quarter 2025:","length":20,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Worldwide net sales were $826.4 million, an increase of 25.7%, or an increase of 24.7% on a constant currency basis.","length":116,"tagName":"p"}]},{"val":[{"type":"text","content":"Base business, excluding Nevro, net sales were $726.7 million, an increase of 10.6%, or an increase of 9.4% on a constant currency basis.","length":137,"tagName":"p"}]},{"val":[{"type":"text","content":"GAAP net income for the quarter was $140.6 million.","length":51,"tagName":"p"}]},{"val":[{"type":"text","content":"GAAP diluted earnings per share (“EPS”) was $1.03, an increase of 442.6%. Non-GAAP diluted EPS was $1.28, an increase of 52.1%.","length":127,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":431,"olType":false},{"type":"text","content":"Full Year 2025:","length":15,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Worldwide net sales were $2,938.9 million, an increase of 16.7%, or an increase of 16.2% on a constant currency basis.","length":118,"tagName":"p"}]},{"val":[{"type":"text","content":"Base business, excluding Nevro, net sales were $2,645.3 million, an increase of 5.0%, or an increase of 4.3% on a constant currency basis.","length":138,"tagName":"p"}]},{"val":[{"type":"text","content":"GAAP net income for the year was $537.9 million.","length":48,"tagName":"p"}]},{"val":[{"type":"text","content":"GAAP diluted EPS was $3.92, an increase of 425.4%. Non-GAAP diluted EPS was $3.98, an increase of 30...

More updates from Globus Medical, Inc.